Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

CRVO stock hub

CervoMed Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

CRVOis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

36.6M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

CRVO

In the news

Latest news · CRVO

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-93.9

P25 -105.6P50 -46.5P75 -3.1

ROIC-61.6

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All CRVO market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

172

Groups with data

Currency

USD

Showing 172 of 172 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001053691
Company name	CervoMed Inc.
Country	United States
Country code	US
Cusip	15713L109
Employees	15
Employees Change	7%
Employees Change Percent	87.5
Enterprise value	$15.7M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
Isin	US15713L1098
Last refreshed	2026-05-10
Market cap	$36.6M
Market cap category	Nano-Cap
Price	$3.95
Price currency	USD
Rev Per Employee	267,100.67x
Sector	Healthcare
Sic	2834
Symbol	CRVO
Website	https://www.cervomed.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-73.74%
EV/Sales	3.92x
P/B ratio	2.01x
P/S ratio	9.13x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross Profit	$-17.8M
Net Income	$-27M
Net Income Growth Years	0%
Pretax Margin	-673.06%
Profit Per Employee	$-1.8M
ROA	-53.62
ROCE	-155.3
ROE	-93.92
ROIC	-61.59

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-55.69%
EPS Growth Years	0
Revenue Growth	-58.86x
Revenue Growth Q	-99.6x
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.12
Assets	$22.9M
Cash	$20.9M
Current Assets	$22.9M
Current Liabilities	$4.7M
Equity	$18.2M
Liabilities	$4.7M
Long Term Assets	$0
Long Term Liabilities	$0
Net Cash	$20.9M
Net Cash By Market Cap	$57.05
Net Cash Growth	-46.39%
Net Debt Equity	$-1.14
Tangible Book Value	$18.2M
Tangible Book Value Per Share	$1.97
WACC	-20.34

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	4.91
Net Working Capital	$-2.6M
Quick ratio	4.57
Working Capital	$18.2M
Working Capital Turnover	$0.14

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-12%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-55.67%
200-day SMA	6.87
50-day SMA	4
50-day SMA vs 200-day SMA	50under200
All Time High	26.38
All Time High Change	-85.03%
All Time High Date	2024-03-20
All Time Low	1.8
All Time Low Change	119.44%
All Time Low Date	2024-12-17
ATR	0.26
Beta	-4.47
Beta1y	0.62
Beta2y	-0.08
Ch YTD	-50
High	4.15
High52	13.13
High52 Date	2025-07-28
High52ch	-69.92%
Low	3.81
Low52	3.51
Low52 Date	2026-03-30
Low52ch	12.54%
Ma50ch	-1.25%
Price vs 200-day SMA	-42.54%
RSI	52.16
RSI Monthly	44.97
RSI Weekly	35.87
Sharpe ratio	-0.85x
Sortino ratio	-1.13
Total Return	-12%
Tr YTD	-50
Tr1m	2.87%
Tr1w	6.47%
Tr3m	-25.61%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	6
Analyst Count Top	2
Analyst Price Target Top	$16
Analyst Ratings	Strong Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$-0.81
Earnings Revenue Estimate	90,000x
Earnings Revenue Estimate Growth	-95.31x
Operating Income	$-28.3M
Operating margin	-706.2
Price target	$23
Price Target Change	$482
Price Target Change Top	$305

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	6,292,269%
Float Percent	67.96%
Shares Insiders	32.04%
Shares Institutions	14.54%
Shares Out	9,258,719
Shares Qo Q	0.03%
Shares Yo Y	12%
Short Float	4.36%
Short Ratio	5.9
Short Shares	2.96

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	40,896.45x
Bv Per Share	1.97
Ch1m	2.87
Ch1w	6.47
Ch1y	-55.67
Ch3m	-25.61
Ch6m	-42.92
Change	3.95%
Change From Open	2.86
Close	3.8
Days Gap	1.05
Dollar Volume	237,347.6
Earnings Date	2026-05-12
Earnings Time	bmo
EBIT	$-28.3M
EPS	$-2.98
F Score	1
Financing CF	4,588,687
Fiscal Year End	December
Founded	2,001
Investing CF	18,097,249
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-03-17
Last Report Date	2025-12-31
Last Split Type	Never
Last10k Filing Date	2026-03-13
Ma150	6.14
Ma150ch	-35.71%
Ma20	3.86
Ma20ch	2.36%
Net CF	-764,027
Next Earnings Date	2026-05-22
Open	3.84
Optionable	No
Position In Range	40.82
Post Close	3.95
Postmarket Change Percent	-1.52
Postmarket Price	$3.89
Price Date	2026-05-08
Ptbv Ratio	2.01
Relative Volume	1.47x
Revenue	4,006,510x
SBC By Revenue	36.16x
Share Based Comp	1,448,634
Tr6m	-42.92%
Us State	Massachusetts
Volume	60,088
Z Score	-0.55

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does CRVO pay a dividend?

Capital-return profile for this ticker.

Performance

CRVO stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns CRVO?

Insider, institutional, and short-interest positioning.

Institutional ownership

+14.5%

Float: +68.0% of shares outstanding

Insider ownership

+32.0%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

CRVO momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

52.2

Neutral momentum band

Price vs 200-day MA

-42.5%

50/200-day relationship not available

Beta (5Y)

-4.47

Less volatile than the market

Sharpe ratio

-0.85

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About CRVO

Hub-level FAQ points readers to the deeper analysis pages.

What is the current CRVO stock rating?

CervoMed Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full CRVO analysis?

The full report lives at /stocks/CRVO/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for CRVO?

The latest report frames CRVO around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the CRVO page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.